Olprinone HCl, within Loncom Pharma's Cardiovascular APIS, offers solutions for specific cardiac conditions, contributing to improved patient health and well-being.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
